Intelligence · Clinical Pipeline
PARItec Pipeline
All ClinicalTrials.gov programs at PARItec — phase, modality, and trial IDs.
- Programs
- 17
Quick answer
PARItec has 17 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
-
-, -, SULFAMETHOXAZOLE AND TRIMETHOPRIM
Pari Pharma GmbH
Pyelonephritis, Kidney Transplant recipients
1 trial -
AMOXICILLIN
Pari Pharma GmbH
Adults diagnosed with lower limbs erysipelas
1 trial -
AMOXICILLIN AND BETA-LACTAMASE INHIBITOR , CEFEPIME , CEFOTAXIME, SPIRAMYCIN , PIPERACILLIN AND BETA-LACTAMASE INHIBITOR
Pari Pharma GmbH
EA-COPD (with mechanical ventilation, invasive or non-invasive, or high-flow nasal oxygen therapy).
1 trial -
AMPICILLIN , AMOXICILLIN AND BETA-LACTAMASE INHIBITOR , OFLOXACIN , MOXIFLOXACIN , AZITHROMYCIN , LEVOFLOXACIN , AMOXICILLIN , PRISTINAMYCIN , ERYTHROMYCIN , CIPROFLOXACIN , CLARITHROMYCIN
Pari Pharma GmbH
Community acquired pneumonia (CAP)
1 trial -
BILINDA GYNIAL 0,03 mg/2 mg Filmtabletten, Selina Gynial 0,03 mg/0,15 mg Filmtabletten
Pari Pharma GmbH
Hormonal contraception
1 trial -
CEFAZOLIN
Pari Pharma GmbH
Infection prophylaxis
1 trial -
DONEPEZIL, DONEPEZIL
Pari Pharma GmbH
Interest of adding donepezil to the non-medicinal care pathway recommended in France for Alzheimer's disease
1 trial -
Enema transplant of fecal microbiota, Placebo double encapsulated oral transplant of fecal microbiota, Placebo coloscopic transplant of Fecal microbiota, Double encapsulated oral transplant of fecal microbiota
Pari Pharma GmbH
Crohn’s disease
1 trial -
MEROPENEM AND VABORBACTAM , LINEZOLID , TEDIZOLID , SULFAMETHOXAZOLE AND TRIMETHOPRIM , -, CEFTAZIDIME AND BETA-LACTAMASE INHIBITOR , -, DAPTOMYCIN , -, COLISTIN , -, METRONIDAZOLE , AMIKACIN , IMIPENEM, CILASTATIN AND RELEBACTAM
Pari Pharma GmbH
Pyogenic liver abscess
1 trial -
MUCODRILL 600 mg SANS SUCRE, comprimé effervescent édulcoré au sucralose, FOLINORAL 25 mg, gélule, VITAMINE B12 GERDA 250 microgrammes, comprimé sécable, Omacor 1000 mg capsules molles
Pari Pharma GmbH
Ultra High Risk of psychosis and first episode psychosis
1 trial -
PREDNISONE
Pari Pharma GmbH
Idiopathic retroperitoneal fibrosis
1 trial -
RIVAROXABAN , RIVAROXABAN, RIVAROXABAN
Pari Pharma GmbH
Patients with excessive supraventricular ectopies or short atrial runs (ESVEA) defined as ≥ 1% premature atrial contractions (PAC) /24 hours or any atrial runs ≥ 20 PACs (but shorter than 30 seconds) on a 24-hour Holter ECG monitoring and CHA2DS2VASC score ≥ 3. Patients with any atrial runs ≥ 20 PACs but shorter than 30 seconds on a 15-21 days Holter ECG monitoring and CHA2DS2VASC score ≥ 3 may also be included in the Short-Run trial.
1 trial -
Regiocit solution pour hémofiltration
Pari Pharma GmbH
Adult patients hospitalized in intensive care with an indication of EER with ARC during the stay.
1 trial -
Repatha 140 mg solution for injection in pre-filled pen
Pari Pharma GmbH
acute myocardial infarction
1 trial -
TIMOFEROL 50 mg, comprimé enrobé, TIMOFEROL, gélule, FERRIC CARBOXYMALTOSE
Pari Pharma GmbH
Women who delivered by caesarean and have a moderate postpartum iron deficiency anaemia defined by 8.0 g/dL ≤ postoperative Hb level ≤ 10.0 g/dL within 72h after delivery and a ferritinemia ≤ 100 ng/mL OR transferrin saturation ≤ 20% (Measured after postoperative Hb level measurement)
1 trial -
VERAPAMIL , NEBIVOLOL , PROPAFENONE , BISOPROLOL , AMIODARONE , FLECAINIDE , SOTALOL , DILTIAZEM
Pari Pharma GmbH
Asymptomatic Patients with frequent PVCs and normal LVEF
1 trial -
Xolair 75 mg solution for injection in pre-filled syringe
Pari Pharma GmbH
Well controlled severe allergic asthma
1 trial
Frequently asked questions
How many pipeline programs does PARItec have?
17 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.
Data attribution: Data sources · All pipeline programs